期刊文献+

人肝癌细胞系HC-108的建立及其生物学特征 被引量:1

ESTABLISHMENT AND CHARACTERIZATION OF A NEW HUMAN HEPATOCELLULAR CARCINOMA CELL LINE HC-108
下载PDF
导出
摘要 HC108细胞系为贴壁生长具有上皮细胞形态特征的分化程度较高的人肝癌细胞。AFP分泌阴性,细胞平均倍增时间为32.21小时,细胞分裂指数为27.75‰,软琼脂克隆形成率为5.0%,能形成裸鼠移植瘤,支原体为阴性。染色体和流式细胞术分析为超二倍体核型,17号染色体改变最为明显。 A new human hepatocellular carcinoma cell line from surgical hepatocellular carcinoma tissue of a patient has been established. The morphological changes of the cell was examined under light and electron microscopy. The growth curve and cloning efficiency of the cultured HC-108 Cells were investigated. The chromosome and cell cycle were analyzed by G-banding and flow cytometry. The tumorigenesis on nude mice and mycoplasma were studied. The epithelial cell line has not secreted alpha - fetoprotein. A doubling time of 32. 21h in medium RPMI-1640 supplemented with 10% CS and 5.0% clonal efficiency in soft agar were observed. When they were transplanted subcutaneously into the back of athymic nude mice(balb/c,nu/nu) .tumors were formed at the sites of inoculation,which were shown to be hepatocellular carcinoma,similar in morphology to the original tumor from which they were derived. HC- 108 cells had a chromosome mode of 80 - 100 with one identifiable marker.
出处 《细胞生物学杂志》 CAS CSCD 北大核心 2002年第4期249-251,T003,共4页 Chinese Journal of Cell Biology
关键词 人肝癌细胞系 HC-108 生物学特征 Hepatocellular carcinoma Cell line Biology
  • 相关文献

参考文献3

二级参考文献10

共引文献12

同被引文献9

  • 1颜子颖 王海林.精编分子生物学实验指南[M].北京:科学出版社,1998.17-287.
  • 2Gavilondo-cowley JV, Coloma M J, Vazuez J, et al. Specific amplification of rearranged immunoglobulin variable region genes from mouse Hybridoma cells [ J ]. Hybridoma, 1990; 9 ( 5 ) :407 - 416.
  • 3Warrens AN, Jones MD, Lechler RI. Splicing by overlap extension by PCR using asymmetric amplification: An improved technique for the generation of hybrid proteins of immunological interest [ J ].Gene, 1997;186(1) :29 -35.
  • 4Chio CL, Huff, Rita M. Binding assay employing a synthetic gene for D4 dopamine receptors [ J]. Biotechnol Advances, 1997; 15 ( 1 ):72 -73.
  • 5Varela M, Sala M, Llovet JM, et al. Treatment of hepatocellular carcinoma: Is there an optimal strategy? [J]. Cancer Treat Rev,2003 ;29(2) :99 - 104.
  • 6Zhang J, Liu YF, Yang SJ, et al. Primary targeting of recombinant Fv-immunotoxin hscFv25-mTNF against hepatocellular carcinoma[J]. World J Gastroenterol, 2004;10(13) :1872 - 1875.
  • 7王小平,陈葳,李旭,付伟,阎春芳,杨玉琮,程小丽.抗人肝癌单克隆抗体HCD78的制备及免疫组化定位[J].细胞与分子免疫学杂志,1999,15(2):140-141. 被引量:2
  • 8毕向军,杨冬华,崔俊,李鹏,宁晓燕,范子荣,覃汉荣.抗肝癌单链抗体的构建及其结合特性[J].上海免疫学杂志,2001,21(5):289-292. 被引量:4
  • 9李赏,胡宝成,绳纪坡,黄培堂.肝癌细胞特异性结合抗体的筛选及序列测定[J].免疫学杂志,2002,18(B06):20-21. 被引量:5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部